StockData
Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. (ARMP) stock

ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$2.66−0.33 (-11.04%)

Close on Nov 17, 2026Market cap $98.90MP/E –Yield –

Armata Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Armata Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$25.42M. For fiscal 2025 it was -$25.76M. The highest annual figure on record is -$6.29M in fiscal 2013.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$25.76M–
FY2024Dec 31, 2024-$37.55M–
FY2023Dec 31, 2023-$47.42M–
FY2022Dec 31, 2022-$32.48M–
FY2021Dec 31, 2021-$23.58M–
FY2020Dec 31, 2020-$18.27M–
FY2019Dec 31, 2019-$15.58M–
FY2018Dec 31, 2018-$10.63M–
FY2017Dec 31, 2017-$9.19M–
FY2016Dec 31, 2016-$10.61M–
FY2015Dec 31, 2015-$9.78M–
FY2014Dec 31, 2014-$12.57M–
FY2013Dec 31, 2013-$6.29M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$8.67M–
Q1 FY2026Mar 31, 2026-$5.78M–
Q4 FY2025Dec 31, 2025-$6.67M–
Q3 FY2025Sep 30, 2025-$4.30M–
Q2 FY2025Jun 30, 2025-$7.21M–
Q1 FY2025Mar 31, 2025-$7.58M–
Q4 FY2024Dec 31, 2024-$7.93M–
Q3 FY2024Sep 30, 2024-$8.86M–
Q2 FY2024Jun 30, 2024-$10.18M–
Q1 FY2024Mar 31, 2024-$10.58M–
Q4 FY2023Dec 31, 2023-$8.11M–
Q3 FY2023Sep 30, 2023-$9.69M–
Q2 FY2023Jun 30, 2023-$12.06M–
Q1 FY2023Mar 31, 2023-$17.57M–
Q4 FY2022Dec 31, 2022-$10.49M–
Q3 FY2022Sep 30, 2022-$10.33M–
Q2 FY2022Jun 30, 2022-$8.15M–
Q1 FY2022Mar 31, 2022-$3.52M–
Q4 FY2021Dec 31, 2021-$8.60M–
Q3 FY2021Sep 30, 2021-$4.96M–
Q2 FY2021Jun 30, 2021-$4.54M–
Q1 FY2021Mar 31, 2021-$5.48M–
Q4 FY2020Dec 31, 2020-$6.30M–
Q3 FY2020Sep 30, 2020-$3.88M–
Q2 FY2020Jun 30, 2020-$3.86M–
Q1 FY2020Mar 31, 2020-$4.23M–
Q4 FY2019Dec 31, 2019-$2.73M–
Q3 FY2019Sep 30, 2019-$4.57M–
Q2 FY2019Jun 30, 2019-$5.83M–
Q1 FY2019Mar 31, 2019-$2.46M–
Q4 FY2018Dec 31, 2018-$3.20M–
Q3 FY2018Sep 30, 2018-$2.02M–
Q2 FY2018Jun 30, 2018-$1.88M–
Q1 FY2018Mar 31, 2018-$3.54M–
Q4 FY2017Dec 31, 2017-$2.37M–
Q3 FY2017Sep 30, 2017-$593.00K–
Q2 FY2017Jun 30, 2017-$2.93M–
Q1 FY2017Mar 31, 2017-$3.30M–
Q4 FY2016Dec 31, 2016-$1.50M–
Q3 FY2016Sep 30, 2016-$3.13M–

More Armata Pharmaceuticals figures

See a number that looks wrong?